125I粒子组织间植入治疗腹腔实质性脏器恶性肿瘤的临床观察

    Clinical observation of 125I interstitial brachytherapy for abdominal malignant tumor

    • 摘要: 目的:探讨放射性125I粒子组织间植入治疗腹腔实质性脏器恶性肿瘤的应用价值。方法:原发性和转移性肝癌5例,在CT引导下组织间植入125I粒子;4例胰腺癌和1例转移性肝癌在开腹术中超声引导下组织间植入125I粒子。随访1~12个月观察疗效。结果:10例均顺利完成粒子植入,技术成功率100%;5例术前有疼痛病史,术后临床疼痛症状明显改善,无严重并发症;术后2个月CT观察肿瘤体积均有不同程度缩小,有效率达90%。结论:放射性125I粒子组织间植入治疗腹腔实质性脏器恶性肿瘤能有效缓解症状,提高患者生活质量。

       

      Abstract: Objective: To assess the clinical observation of radioactive 125I seeds interstitial brachytherapy for abdominal malignant tumors.Methods: Five patients with primary and metastatic liver cancer received 125I seeds interstitial brachytherapy under CT.Four cases of pancreatic cancer and 1 case of metastatic liver cancer were treated with 125I interstitial brachytherapy during laparotomy under outrasound guidance,and the follow-up lasted for 1-12 months.Results: The implanting was successfully in all the 10 cases.The pains were relieved obviously in 5 caes and no severe complications were observed.CT showed that the volume of the malignant tumors decreased to some extent during the 2-month follow-up,with an overall response rate of 90%.Conclusions: Radioactive seeds interstitial brachytherapy may relieve the symptoms of patients with abdominal malignant tumors and improve their life quality.

       

    /

    返回文章
    返回